K. Mehta

1.6k total citations
28 papers, 1.1k citations indexed

About

K. Mehta is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K. Mehta has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K. Mehta's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (8 papers). K. Mehta is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (11 papers) and Advanced Breast Cancer Therapies (8 papers). K. Mehta collaborates with scholars based in Germany, United States and Switzerland. K. Mehta's co-authors include Sibylle Loibl, Gϋnter von Minckwitz, B. Gerber, Holger Eidtmann, Christian Jackisch, Jens Huober, Sherko Kümmel, J. Hilfrich, Claus Hanusch and Serban Dan Costa and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

K. Mehta

27 papers receiving 1.0k citations

Peers

Countries citing papers authored by K. Mehta

Since Specialization

Citations

This map shows the geographic impact of K. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Mehta more than expected).

Fields of papers citing papers by K. Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Mehta. The network helps show where K. Mehta may publish in the future.

Co-authorship network of co-authors of K. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of K. Mehta. A scholar is included among the top collaborators of K. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Mehta. K. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypercalcaemia of malignancy: a case of vitamin-D-mediated hypercalcaemia in lymphoma 2024 ·BMJ Case Reports ·K. Mehta, (unknown), (unknown), Simerjot K Jassal	2
2	Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer 2017 ·Breast Cancer Research and Treatment ·Sonia L. Villegas, Silvia Darb‐Esfahani, Gϋnter von Minckwitz, Jens Huober, Karsten E. Weber, Frederik Marmé, Jenny Furlanetto, Christian Schem, Berit M. Pfitzner, Bianca Lederer, Knut Engels, Sherko Kümmel, Volkmar Müller, K. Mehta, Carsten Denkert, Sibylle Loibl	9
3	Transvaginal ultrasound (TVUS)-guided biopsy is safe and effective in diagnosing peritoneal carcinomatosis and recurrent pelvic malignancy 2016 ·Clinical Radiology ·(unknown), M.J. Weston, (unknown), Jennifer Graham, K. Mehta, Nafisa Wilkinson, John Spencer	5
4	Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial 2013 ·Annals of Oncology ·Carsten Denkert, Sibylle Loibl, Berit Müller, Holger Eidtmann, Wolfgang Schmitt, W. Eiermann, B. Gerber, Hans Tesch, J. Hilfrich, Jens Huober, Tanja Fehm, Jana Barinoff, Christian Jackisch, Judith Prinzler, Thomas Rüdiger, E Erbstösser, Jens‐Uwe Blohmer, Jan Budczies, K. Mehta, Gϋnter von Minckwitz	172
5	Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) 2013 ·Annals of Oncology ·Gϋnter von Minckwitz, Mahdi Rezai, Peter A. Fasching, Jens Huober, Hans Tesch, Ingo Bauerfeind, J. Hilfrich, Holger Eidtmann, B. Gerber, Claus Hanusch, Jens‐Uwe Blohmer, Serban Dan Costa, Christian Jackisch, Stefan Paepke, Andreas Schneeweiß, Sherko Kümmel, Carsten Denkert, K. Mehta, Sibylle Loibl, Michael Untch	51
6	Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer 2013 ·Annals of Oncology ·Bruno V. Sinn, Gϋnter von Minckwitz, Carsten Denkert, Holger Eidtmann, Silvia Darb‐Esfahani, Hans Tesch, Ralf Kronenwett, G. M. Hoffmann, Antje Belau, (unknown), H.-J. Holzhausen, Sven-Thomas Graßhoff, Klaus Baumann, K. Mehta, Manfred Dietel, Sibylle Loibl	30
7	8O_PR MUCIN-1 Protein and Mrna Expression in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy 2012 ·Annals of Oncology ·Bruno V. Sinn, Gϋnter von Minckwitz, Carsten Denkert, Holger Eidtmann, Silvia Darb‐Esfahani, Antje Belau, Ralf Kronenwett, (unknown), K. Mehta, Sibylle Loibl	0
8	S3-2: Neoadjuvant Chemotherapy Adapted by Interim Response Improves Overall Survival of Primary Breast Cancer Patients – Results of the GeparTrio Trial. 2011 ·Cancer Research ·G von Minckwitz, Jens‐Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, W. Eiermann, B. Gerber, Claus Hanusch, J. Hilfrich, Jens Huober, C Jackisch, M. Kaufmann, Sherko Kümmel, Stefan Paepke, Andreas Schneeweiß, Michael Untch, D-M. Zahm, K. Mehta, Sibylle Loibl	28
9	OT3-01-15: Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Advanced Breast Cancer: The LEA Study. 2011 ·Cancer Research ·(unknown), (unknown), Miguel Martín, Serafín Morales, Carmen Crespo, Ángel Guerrero, (unknown), (unknown), Montserrat Muñoz-Mateu, Eva Carrasco, (unknown), (unknown), Bahriye Aktas, Winfried Schoenegg, (unknown), K. Mehta, Sibylle Loibl, (unknown)	2
10	Validation of p95 as a predictive marker for trastuzumab-based therapy in primary HER2-positive breast cancer: A translational investigation from the neoadjuvant GeparQuattro study. 2011 ·Journal of Clinical Oncology ·Sibylle Loibl, Jean Marie Bruey, Gϋnter von Minckwitz, Jens Huober, MF Press, Silvia Darb‐Esfahani, Christine Solbach, Carsten Denkert, Hans Tesch, Frank Holms, Tanja Fehm, K. Mehta, Michael Untch	35
11	First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial 2010 ·European Journal of Cancer ·M. Kaufmann, Nicolaì Maass, Serban Dan Costa, Andreas Schneeweiß, Sibylle Loibl, Marc Sütterlin, Iris Schrader, B. Gerber, Wolfgang Bauer, W. Wiest, (unknown), (unknown), Volker Hagen, Anke Kleine-Tebbe, Eugen Ruckhaeberle, K. Mehta, Gϋnter von Minckwitz	30
12	5002 MoniCa: A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer (GBG39) 2009 ·European Journal of Cancer Supplements ·M. Kaufmann, Marc Sütterlin, Iris Schrader, B. Gerber, Wolfgang Bauer, Christoph Mundhenke, W. Wiest, K. Mehta, Sibylle Loibl, Gϋnter von Minckwitz	4
13	ZORO: A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37) 2009 ·Journal of Clinical Oncology ·B. Gerber, (unknown), (unknown), Nicolaì Maass, Diana Fischer, Harald Sommer, Bettina Conrad, K. Mehta, Sibylle Loibl	15
14	5011 ZORO: Prospective randomized multicenter-study to prevent chemotherapy induced ovarian failure with the GnRH-Agonist Goserelin in young hormone insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37) 2009 ·European Journal of Cancer Supplements ·B. Gerber, Gϋnter von Minckwitz, (unknown), (unknown), Nicolaì Maass, Diana Fischer, (unknown), Bettina Conrad, K. Mehta, S. Loibl	16
15	Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study 2008 ·JNCI Journal of the National Cancer Institute ·Gϋnter von Minckwitz, Sherko Kümmel, (unknown), Claus Hanusch, Holger Eidtmann, J. Hilfrich, B. Gerber, Jens Huober, Serban Dan Costa, Christian Jackisch, Sibylle Loibl, K. Mehta, (unknown)	182
16	Neoadjuvant treatment of HER2 overexpressing primary breast cancer with trastuzumab given concomitantly to epirubicin/ cyclophosphamide followed by docetaxel ± capecitabine. First analysis of efficacy and safety of the GBG/AGO multicenter intergroup-study “GeparQuattro” 2008 ·European Journal of Cancer Supplements ·Michael Untch, (unknown), Sibylle Loibl, Peter A. Fasching, Jens Huober, Hans Tesch, Ingo Bauerfeind, J. Hilfrich, K. Mehta, Gϋnter von Minckwitz	16
17	Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial 2008 ·JNCI Journal of the National Cancer Institute ·G von Minckwitz, Sherko Kümmel, (unknown), Claus Hanusch, Holger Eidtmann, (unknown), B. Gerber, J. Huober, S. D. Costa, Christian Jackisch, Sibylle Loibl, K. Mehta, (unknown), (unknown)	210
18	Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients—a double-blind, randomized study 2007 ·Annals of Oncology ·Sibylle Loibl, Kathrin Schwedler, Gϋnter von Minckwitz, Renate Strohmeier, K. Mehta, M. Kaufmann	68
19	Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study 2007 ·Annals of Oncology ·Gϋnter von Minckwitz, Sherko Kümmel, Andreas du Bois, W. Eiermann, Holger Eidtmann, B. Gerber, J. Hilfrich, Jens Huober, Serban Dan Costa, Christian Jackisch, Sven-Thomas Graßhoff, Sabine Vescia, Tomáš Skácel, Sibylle Loibl, K. Mehta, M. Kaufmann	117
20	Clonidine vs. venlafaxine as treatment for hot flashes in breast cancer patients: A double-blind randomised study 2005 ·Journal of Clinical Oncology ·Sibylle Loibl, Kathrin Schwedler, Gϋnter von Minckwitz, Renate Strohmeier, K. Mehta, M. Kaufmann	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact